Back to News
Market Impact: 0.28

Bank of America says these stocks have more room to run, including one tech giant

Source: CNBC

+4
Analyst InsightsArtificial IntelligenceCorporate Guidance & OutlookCompany FundamentalsBanking & LiquidityTransportation & LogisticsTechnology & Innovation
Bank of America says these stocks have more room to run, including one tech giant

Bank of America highlighted Microsoft, UBS, Expeditors International, Timken and First Horizon as attractive buy-rated opportunities, emphasizing upside in earnings, valuation and strategic execution. Microsoft’s Azure growth accelerated to 43% in fiscal 4Q26 from 39% in 3Q26, with 45% growth guided for fiscal 1Q27; BofA raised its price target to $600 from $500. The bank also cited Timken’s transition toward higher-margin automation exposure, First Horizon’s 2.75% dividend yield and potential to sustain 15%+ return on capital, UBS’s wealth-management and capital-markets growth, and Expeditors’ debt-free balance sheet.

Analysis

The strongest mechanism is MSFT’s ability to convert AI demand into recurring cloud revenue while spreading infrastructure costs across a broad software installed base. The key debate is no longer whether Azure can grow, but whether incremental AI revenue carries enough gross-margin dilution to justify a premium multiple; investor focus should shift to capex intensity, Azure gross margin, and commercial remaining-performance-obligation growth over the next two earnings prints. A sustained reacceleration in non-AI cloud workloads would broaden the upside, while hyperscaler capex fatigue or weaker enterprise seat growth would quickly challenge the valuation case.

TKR offers a cleaner cyclical-to-secular rerating setup than a generic industrial long: portfolio pruning can lift margins even if broad manufacturing activity remains soft. The second-order beneficiary is factory-automation spending, but the stock’s prior appreciation makes execution—not merely improving PMI—necessary for further upside. A weaker-than-expected order intake or failure to demonstrate mix-driven margin expansion would expose it to de-rating toward conventional industrial-cycle multiples over the next 1-3 months.

FHN and UBS are differentiated financials expressions. FHN’s upside depends on deposit-cost discipline, credit normalization, and eventual strategic optionality; stability alone is insufficient if loan growth remains muted. UBS has the more attractive 6-18 month earnings torque if wealth-management asset inflows and capital-markets activity improve while regulatory capital outcomes remain manageable, but a stricter Swiss capital framework is the primary thesis risk. EXPD is fundamentally defensive but freight forwarding remains tied to trade volumes and rate normalization, making it a watch-list candidate rather than a high-conviction directional trade.

Consensus may be overvaluing analyst target revisions as independent catalysts. The actionable opportunity is dispersion: own companies with identifiable earnings-revision drivers and avoid treating a broad collection of buy ratings as a single risk-on signal.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

moderately positive

Sentiment Score

0.56

Ticker Sentiment

BAC0.18
EXPD0.58
FHN0.68
MSFT0.82
TKR0.72
UBS0.63

Key Decisions for Investors

  • Initiate a 3-6 month long MSFT / short AMZN pair, sized modestly: MSFT has superior software monetization and enterprise distribution for AI, while AMZN retains greater retail-margin and capex sensitivity. Reassess if Azure growth decelerates materially or Microsoft signals further capex acceleration without corresponding cloud-margin support.
  • Buy TKR on a 5-8% market- or PMI-driven pullback rather than chase strength; target a 6-12 month holding period. The thesis requires rising segment margins and resilient automation-related orders, with a stop/review trigger on consecutive quarters of negative organic growth without margin improvement.
  • Accumulate UBS over 6-18 months as a European wealth-management and capital-markets recovery vehicle; hedge sector beta through a partial short in a broad European bank ETF such as EUFN. Reduce exposure if Swiss capital-rule proposals imply a materially higher CET1 burden than management can offset through earnings or buybacks.
  • Keep FHN as a watch item pending evidence of improving net interest income, deposit-cost stabilization, and benign criticized-loan trends. A long is attractive only if those metrics support durable returns above the market’s regional-bank discount; deteriorating commercial real-estate credit would falsify the stability thesis.
  • Do not initiate EXPD solely on the rating. Set an alert for improving global air/ocean freight volumes or a sustained share-gain signal; absent that, its balance-sheet quality is likely already reflected in a defensive valuation.

More News